A TBX5 NONSENSE MUTATION IN SIBLINGS WITH DIVERGENT PHENOTYPES ASSOCIATED WITH ISOLATED SEPTAL DEFECTS
DOI:
https://doi.org/10.22159/ajpcr.2017.v10i9.19628Keywords:
T-box gene, TBX5, Septal defect, Gene variant, Transcription factor, DNA sequencingAbstract
Â
 Objective: Heart septal defects (HSD) account for 50% of the congenital heart malformations and are characterized by the hole in the wall of tissue which separates the heart chambers. The known causes of the SD are multifactorial and complex inheritance.
Methods: Isolated 15 subjects with ostium secundum atrial SD (OS-ASD) and one subject with perimembranous ventricular SD (VSD) among 125 clinically diagnosed SD were included in the study. Sanger sequencing was performed for all the exons of TBX5 genes using genomic DNA of these patients.
Results: Sequence variation c.444 G>A substitution, leads to the alteration of tryptophan residue into premature stop codon at codon 148. We observed a divergent phenotype within a family of four, where one sibling and the mother had OS-ASD, another sibling had phenotype of perimembranous VSD, and the father had normal genotype.
Conclusion: We believe that this novel sequence variant in TBX5 gene is one of the factors in the SD and may hold a key determining the role of TBX5 gene in the heart development.
Downloads
References
Pierpont ME, Basson CT, Benson DW Jr, Gelb BD, Giglia TM, Goldmuntz E, et al. American heart association congenital cardiac defects committee, council on cardiovascular disease in the young. Genetic basis for congenital heart defects: Current knowledge: A scientific statement from the American heart association congenital cardiac defects committee, council on cardiovascular disease in the young: Endorsed by the American academy of pediatrics. Circulation 2007;115:3015-38.
Gelb BD, Chung WK. Complex genetics and the etiology of human congenital heart disease. Cold Spring Harb Perspect Med 2014;4(7):a013953.
McCulley DJ, Black BL. Transcription factor pathways and congenital heart disease. Curr Top Dev Biol 2012;100:253-77.
Granados-Riveron JT, Pope M, Bu’lock FA, Thornborough C, Eason J, Setchfield K, et al. Combined mutation screening of NKX2-5, GATA4, and TBX5 in congenital heart disease: Multiple heterozygosity and novel mutations. Congenit Heart Dis 2012;7(2):151-9.
Hiroi Y, Kudoh S, Monzen K, Ikeda Y, Yazaki Y, Nagai R, et al. Tbx5 associates with Nkx2-5 and synergistically promotes cardiomyocyte differentiation. Nat Genet 2001;28(3):276-80.
Ghosh TK, Packham EA, Bonser AJ, Robinson TE, Cross SJ, Brook JD. Characterization of the TBX5 binding site and analysis of mutations that cause Holt-Oram syndrome. Hum Mol Genet 2001;10(18):1983-94.
Basson CT, Huang T, Lin RC, Bachinsky DR, Weremowicz S, Vaglio A, et al. Different TBX5 interactions in heart and limb defined by Holt-Oram syndrome mutations. Proc Natl Acad Sci U S A 1999;96(6):2919-24.
Borozdin W, Bravo Ferrer Acosta AM, Bamshad MJ, Botzenhart EM, Froster UG, Lemke J, et al. Expanding the spectrum of TBX5 mutations in Holt-Oram syndrome: Detection of two intragenic deletions by quantitative real time PCR, and report of eight novel point mutations. Hum Mutat 2006;27(9):975-6.
Guo Q, Shen J, Liu Y, Pu T, Sun K, Chen S. Exome sequencing identifies a c.148-1G>C mutation of TBX5 in a Holt-Oram family with unusual genotype-phenotype correlations. Cell Physiol Biochem 2015;37(3):1066-74.
van der Bom T, Zomer AC, Zwinderman AH, Meijboom FJ, Bouma BJ, Mulder BJ. The changing epidemiology of congenital heart disease. Nat Rev Cardiol 2011;8(1):50-60.
Kent WJ. BLAT-the BLAST-like alignment tool. Genome Res 2002;12:656-64.
Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, et al. The human genome browser at UCSC. Genome Res 2002;12:996-1006.
Schwarz JM, Rödelsperger C, Schuelke M, Seelow D. MutationTaster evaluates disease-causing potential of sequence alterations. Nat Methods 2010;7(8):575-6.
Mi H, Poudel S, Muruganujan A, Casagrande JT, Thomas PD. PANTHER version 10: Expanded protein families and functions, and analysis tools. Nucleic Acids Res 2016;44:D336-42.
Stenson PD, Ball EV, Mort M, Phillips AD, Shiel JA, Thomas NS, et al. Human gene mutation database (HGMD): 2003 update. Hum Mutat 2003;21(6):577-81.
Genomes Project Consortium, Abecasis GR, Altshuler D, Auton A, Brooks LD, Durbin RM, et al. A map of human genome variation from population-scale sequencing. Nature 2010;467(7319):1061-73.
Ashkenazy H, Erez E, Martz E, Pupko T, Ben-Tal N. ConSurf 2010: Calculating evolutionary conservation in sequence and structure of proteins and nucleic acids. Nucleic Acids Res 2010;38:W529-33.
Pradhan L, Gopal S, Li S, Ashur S, Suryanarayanan S, Kasahara H, et al. Intermolecular interactions of cardiac transcription factors NKX2.5 and TBX5. Biochemistry 2016;55(12):1702-10.
Richards AA, Garg V. Genetics of congenital heart disease. Curr Cardiol Rev 2010;6:91-7.
Posch MG, Gramlich M, Sunde M, Schmitt KR, Lee SH, Richter S, et al. A gain-of-function TBX20 mutation causes congenital atrial septal defects, patent foramen ovale and cardiac valve defects. J Med Genet 2010;47(4):230-5.
Bidkar JS, Ghanwat DD, Bhujbal MD, Dama GY. Cardiotonic activity of portulaca oleracea on isolated frog heart. Int J Pharm Pharm Sci 2011;3:118-20.
Wang ZC, Ji WH, Ruan CW, Liu XY, Qiu XB, Yuan F, et al. Prevalence and spectrum of TBX5 mutation in patients with lone atrial fibrillation. Int J Med Sci 2016;13(1):60-7.
Ching YH, Ghosh TK, Cross SJ, Packham EA, Honeyman L, Loughna S, et al. Mutation in myosin heavy chain 6 causes atrial septal defect. Nat Genet 2005;37:423-8.
Shetty K, Shetty R, Rao P, Vivek G, Naveenchandra GS, Razak A, et al. Evaluation of causative factors in amlodipine induced pedal edema. Int J Pharm Pharm Sci 2016;8:303-6.
Kulisz A, Simon HG. An evolutionarily conserved nuclear export signal facilities cytoplasmic localization of the Tbx5 transcription. Mol Cell Biol 2008;28:1553-64.
Stirnimann CU, Ptchelkine D, Grimm C, Müller CW. Structural basis of TBX5-DNA recognition: The T-box domain in its DNA-bound and -unbound form. J Mol Biol 2010;400(1):71-81.
Basson CT, Bachinsky DR, Lin RC, Levi T, Elkins JA, Soults J, et al. Mutations in human TBX5 [corrected] cause limb and cardiac malformation in Holt-Oram syndrome. Nat Genet 1997;15(1):30-5.
Gruenauer-Kloevekorn C, Froster UG. Holt-Oram syndrome: A new mutation in the TBX5 gene in two unrelated families. Ann Genet 2003;46(1):19-23.
Fan C, Duhagon MA, Oberti C, Chen S, Hiroi Y, Komuro I, et al. Novel TBX5 mutations and molecular mechanism for Holt-Oram syndrome. J Med Genet 2003;40(3):e29.
Brassington AM, Sung SS, Toydemir RM, Le T, Roeder AD, Rutherford AE, et al. Expressivity of Holt-Oram syndrome is not predicted by TBX5 genotype. Am J Hum Genet 2003;73(1):74-85.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.